Key Points:
- A COVID-19 vaccine capsule is being developed by Indian pharma firm Premas Biotech in collaboration with an American firm Oramed Pharmaceuticals Inc.
- The efficiency of the oral vaccine capsule – Oravax COVID-19 capsule, has been proven by tests that were performed on animals as part of the vaccine’s pilot study.
- As per reports, another vaccine of Bharat Biotech is also being made in the nasal form along with the University of Wisconsin, which is currently undergoing clinical trials.
Do you want to get vaccinated but, you are scared of needles? Well, this is good news for you then! An Indian Pharma company soon may roll out the COVID-19 vaccine in the form of a capsule that people can take.
New forms of COVID-19 vaccine are currently being developed by multiple pharmaceutical firms around the world. One of these new forms of the COVID-19 vaccine is a capsule that can be directed orally. This COVID-19 vaccine capsule is being developed by Indian pharma firm Premas Biotech.
Premas Biotech is an Indian company that in collaboration with an American firm Oramed Pharmaceuticals Inc on March 19 announced that they are developing an oral COVID-19 vaccine candidate that has shown effectiveness upon administration of a single dose.
The efficiency of the oral vaccine capsule – Oravax COVID-19 capsule, has been proven by tests that were performed on animals as part of the vaccine’s pilot study.
The oral vaccine, upon administration encouraged both systemic immunity by producing Neutralising Antibodies (IgG) as well as (IgA) immune response. These protect the gastrointestinal and respiratory tracts against infection.
Premas Biotech is an Indian company with Dr Prabuddha Kundu as the co-founder and managing director. The Virus-Like Particles in vaccine are manufactured using Premas’ proprietary D-Crypt platform while Oramed has world-leading oral protein delivery platform POD.
These are preliminary results of animal studies while clinical trials will launch soon in the second quarter of 2021.
As per reports, another vaccine of Bharat Biotech is also being made in the nasal form along with the University of Wisconsin, which is currently undergoing clinical trials. In India, the human stage trials for nasal vaccines have begun.
